GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$28.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1 +$9.55M
2 +$7.79M
3 +$6.41M
4
IMVT icon
Immunovant
IMVT
+$6.41M
5
LEGN icon
Legend Biotech
LEGN
+$4.69M

Top Sells

1 +$8.92M
2 +$7.69M
3 +$6.89M
4
ORKA
Oruka Therapeutics
ORKA
+$4.44M
5
DVAX icon
Dynavax Technologies
DVAX
+$3.43M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
1
Cytokinetics
CYTK
$6.92B
$14.9M 7.88%
370,000
+10,000
KALV icon
2
KalVista Pharmaceuticals
KALV
$562M
$11.7M 6.2%
1,014,367
-772,636
EOLS icon
3
Evolus
EOLS
$439M
$11.4M 6.02%
944,743
+49,219
ABVX
4
Abivax
ABVX
$7.06B
$10.2M 5.42%
1,638,111
-10,412
VRDN icon
5
Viridian Therapeutics
VRDN
$2.06B
$10.1M 5.36%
750,000
MRUS icon
6
Merus
MRUS
$7.19B
$9.98M 5.29%
237,156
+79,064
AKBA icon
7
Akebia Therapeutics
AKBA
$803M
$9.55M 5.06%
+4,973,840
XENE icon
8
Xenon Pharmaceuticals
XENE
$3.14B
$8.23M 4.36%
245,272
ASND icon
9
Ascendis Pharma
ASND
$12.2B
$7.79M 4.13%
+50,000
DVAX icon
10
Dynavax Technologies
DVAX
$1.22B
$7.73M 4.09%
595,879
-264,121
IONS icon
11
Ionis Pharmaceuticals
IONS
$11.3B
$7.54M 4%
250,000
-255,007
AMLX icon
12
Amylyx Pharmaceuticals
AMLX
$1.51B
$6.41M 3.4%
+1,811,996
IMVT icon
13
Immunovant
IMVT
$3.3B
$6.41M 3.39%
+375,000
UNCY icon
14
Unicycive Therapeutics
UNCY
$90.6M
$6.31M 3.34%
1,098,000
NGNE icon
15
Neurogene
NGNE
$427M
$5.51M 2.92%
470,964
+28,203
DNTH icon
16
Dianthus Therapeutics
DNTH
$1.31B
$4.99M 2.64%
275,000
LEGN icon
17
Legend Biotech
LEGN
$5.88B
$4.69M 2.48%
+138,240
PCVX icon
18
Vaxcyte
PCVX
$5.48B
$4.36M 2.31%
+115,517
AUTL
19
Autolus Therapeutics
AUTL
$407M
$4.23M 2.24%
2,728,910
-280,482
BBOT
20
BridgeBio Oncology
BBOT
$868M
$4.22M 2.24%
373,833
-126,167
ZURA icon
21
Zura Bio
ZURA
$240M
$4.09M 2.17%
3,170,194
BEAM icon
22
Beam Therapeutics
BEAM
$2.83B
$3.43M 1.82%
+175,562
ACLX icon
23
Arcellx
ACLX
$4.7B
$2.95M 1.56%
+45,000
MREO
24
Mereo BioPharma
MREO
$318M
$2.87M 1.52%
1,275,000
+125,000
CNTX icon
25
Context Therapeutics
CNTX
$113M
$2.87M 1.52%
4,683,711